Healthy and functional cells from discovery
to manufacturing

PAULO A. GARCIA, PH.D.
CEO & Co-Founder

Dr. Paulo A. Garcia co-invented the Flowfect® technology while he was a Research Scientist at MIT. He is currently leading the development and commercialization efforts of the proprietary cell engineering platform for therapeutic and biotechnology applications.

CULLEN R. BUIE, PH.D.
Co-Founder

Cullen R. Buie, Ph.D. is a Tenured Professor of Mechanical Engineering at MIT and co-inventor of the high-throughput genetic modification technology. He brings expertise in the areas of microfluidics, microfabrication, and experimental fluid mechanics to Kytopen.

BETHANY GRANT, M.S.
Head of Research &
Development

Bethany has focused her career on bringing innovative medical device solutions to market. She led concepts through launch and acquisition, and directed innovation and product development at J&J. She graduated from MIT with a B.S. and M.S. in Aeronautical and Astronautical Engineering.

GREG CRESCENZI, M.B.A.
Chief Commercial Officer

As a seasoned business leader, Greg has spent his career leading teams of sales, marketing, product development and operations professionals in commercializing innovative tools and technologies for advancing the development and manufacturing of Biopharmaceuticals with key industry suppliers including Cytiva/GE Healthcare, BD, Pall and Merck Millipore.

JAMES HEMPHILL, PH.D.
Principal Scientist

James Hemphill, Ph.D. is a genetic engineer focused on building new functionality into human cells for therapeutic application. He received his Ph.D. in chemical biology from the University of Pittsburgh and has experience in platform development for adoptive cell therapy.

JESSICA M. SIDO, PH.D.
Scientific Liaison

Jessica M. Sido, Ph.D. graduated from the University of South Carolina School of Medicine where she worked on T cell driven inflammatory responses. She recently completed her postdoctoral research in cancer immunology at Harvard Medical School and Dana-Farber Cancer Institute.

MICHAEL ELLIOTT, M.B.A.
Chief Operating Officer

Michael is an accomplished executive in Operations and P&L Management. Managed various manufacturing and operational functions at BD in Diagnostics, Medical Devices, and Biosciences. More recently, led activities for emerging Biotech firms to hyper-scale their business and operational models globally.

ROSS BEIGHLEY, B.S.
Senior Systems Engineer

Ross Beighley, B.S. graduated from Tufts University where he studied Computer Engineering and Biomedical Engineering. His professional experience centers on transitioning benchtop solutions to worldwide markets through automation.

JOHN ZHAO, M.S.
Process Development Scientist

John Zhao graduated from Cornell with a B.S. in Bioengineering and University of Louisville with a M.S. in Biochemistry. His career has been dedicated to cell therapy in various roles including research, development and manufacturing. His primary focus is innovative process development techniques and applications.

MICHAEL BALADIANG, B.S.
Research Associate

Michael Baladiang, B.S. graduated from the University of Massachusetts Amherst with a degree in biology. He has experience doing work in immunology specifically with efforts in HIV and more recently COVID and focused on optimization and automation of laboratory procedures.

RAMEECH MCCORMACK, M.S.
R&D Engineer

Rameech McCormack, M.S. master’s graduate from the Mechanical Engineering Department at MIT. He is also a co-inventor of the high throughput Flowfect® technology. Rameech leads the effort in product manufacturing, design, and integration.

EDUARDO LATOUCHE, M.S.
Engineering Program Manager

Eduardo is a hands-on technical leader and collaborator tackling complex problems. He has experience leading diverse technical teams in the medical technology space. Eduardo studied Engineering Mechanics (M.S.) and Mechanical Engineering (B.S.) at Virginia Tech.